University of Queensland researchers discovered that nearly 70 per cent of suspected frontotemporal dementia patients ...

Regeneron Pharmaceuticals has announced results from the phase 3 QUASAR trial and its extension study of the phase 3 PULSAR ...

A 20-year study uncovers how the Mediterranean diet can prevent multiple heart conditions and reshape cardiovascular health worldwide.

Discover how your mind filters out distractions. New research reveals the specialized neural mechanisms that actively block ...

COVID-19 vaccination is linked to a transient decrease in hyperthyroidism risk but an increase in hypothyroidism risk over 12 ...

While researchers don’t currently know why women are at greater risk of long COVID, differences in the way men’s and women’s ...

A new study led by the Harvard Pilgrim Health Care Institute examined the effects of a January 2019 Medicare opioid safety policy aimed at reducing high-risk opioid prescribing and related harms among ...

When deciding if reoperation is an option in recurrent glioblastoma, factors like tumor location, therapy history and patient health should be considered.

In a randomized clinical trial, giving the clot-busting medication alteplase up to 24 hours after stroke symptoms first appeared increased the odds of better recovery by 50% compared to those who ...

On January 17, 2025, the US Federal Trade Commission (FTC) released the preliminary observations and findings from its ...

Discover the latest developments in potential ALS treatments with COYA-302 and COYA-303, set to impact the $1.33 billion ...